Fmoc-L-Dap(ivDde)-OH

Fmoc-L-Dap(ivDde)-OH is an Fmoc-protected, stereochemically defined lysine-derived amino acid bearing a side-chain primary amine masked as an ivDde (1,1-dimethyl-2,4-dioxopropylidene ethyl) hydrazone-type protecting group. The molecule contains the chiral L-configuration at the α-carbon, a carboxylic acid for C-terminal activation, and an N-Fmoc group that supports base-labile deprotection during solid-phase peptide synthesis. The ivDde-protected side-chain amine remains inert to many coupling conditions while enabling selective deprotection under hydrazine/acidic conditions to reveal a reactive primary amine for subsequent coupling or conjugation. This combination of orthogonal protecting groups creates a controlled reactivity profile suitable for stepwise peptide construction, amino acid derivatization, and downstream functionalization of the lysine side chain.

1. Peptide Synthesis

Fmoc-L-Dap(ivDde)-OH serves as a protected peptide building block for assembling lysine-analog segments in automated solid-phase peptide synthesis and solution-phase peptide coupling workflows. The Fmoc group enables standard base-mediated N-terminal unmasking, while the ivDde-protected side-chain amine provides orthogonal protection that tolerates amide bond formation without premature side-chain reactivity. The free carboxylic acid functionality supports activation to form peptide bonds at the C-terminus, and the retained L-stereochemistry supports stereochemically consistent incorporation into peptide backbones. Selective ivDde removal can generate a primary amine handle for late-stage branching, crosslinking, or additional peptide extensions, aligning with peptide science strategies that require controlled side-chain presentation.

2. Side-Chain Functionalization

Fmoc-L-Dap(ivDde)-OH is applied in side-chain functionalization workflows where the lysine-derived primary amine must be introduced with temporal control. The ivDde-protected amine can be kept masked during early synthetic steps to avoid uncontrolled N-acylation or coupling, then unmasked to enable targeted transformations such as amide formation, urea/thiourea construction, sulfonamide synthesis, or nucleophilic conjugation chemistry. The presence of the Fmoc group also allows orthogonal sequencing, supporting strategies where N-deprotection and side-chain activation are performed independently to build defined molecular architectures. Downstream derivatives can be used as functionalized peptide analogs, labeling-ready intermediates, or amine-bearing scaffolds for further synthetic elaboration in amino acid chemistry.

3. Chemical Biology Conjugation

Fmoc-L-Dap(ivDde)-OH supports chemical biology and biomolecule modification efforts that require a protected, stereodefined amine for conjugation-ready constructs. The compound's orthogonal protecting groups help manage chemoselectivity when preparing peptide-based probes, affinity tags, or reactive intermediates for bioconjugation chemistry. ivDde deprotection yields a primary amine suitable for coupling to activated esters, isothiocyanates, aldehyde-based reductive amination partners, or other electrophiles commonly used to install functional moieties onto peptide scaffolds. Resulting amine-functionalized peptide conjugates can serve as tools for studying molecular recognition, mapping interaction interfaces, or generating defined probe libraries from amino acid building blocks.

4. Peptidomimetics And SAR Studies

Fmoc-L-Dap(ivDde)-OH can be employed in peptidomimetic construction and structure-activity relationship studies where lysine-like side-chain presentation influences binding and activity profiles. The chiral α-amino acid framework and protected amine enable incorporation into analogs that preserve backbone stereochemistry while varying side-chain chemistry through controlled deprotection and subsequent derivatization. The ability to generate a primary amine at a predetermined stage supports systematic modification of charge, hydrogen-bonding capacity, and linker chemistry, which are key parameters in SAR-focused scaffold optimization. Synthesized analogs derived from this protected intermediate can be advanced into fragment elaboration, library synthesis, or comparative studies of amino acid side-chain effects in peptide-like systems.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-Dap(ivDde)-OH is suitable for industrial fine chemical synthesis routes that require protected amino acid intermediates compatible with scalable peptide-manufacturing operations. The Fmoc group provides a robust N-protection strategy for controlled peptide assembly, while the ivDde-protected side-chain amine supports orthogonal handling to reduce side reactions during sequential coupling steps. The defined stereochemistry and functional group pattern (N-Fmoc, C-terminal carboxylic acid, masked primary amine) align with process chemistry needs for predictable activation and deprotection behavior in downstream manufacturing of peptide intermediates and defined amino acid derivatives. Prepared derivatives from this intermediate can feed into larger synthetic sequences for peptide-based materials, process intermediates, and specialized chemical production where controlled amine unmasking is required for consistent product profiles.

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. The spatiotemporal control of signalling and trafficking of the GLP-1R

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active